- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04054739
Cortical Activity and Gait Function for Robotic Gait Training in Hemiparetic Stroke
9. februar 2020 oppdatert av: Joon-Ho Shin, National Rehabilitation Center, Seoul, Korea
Effects of Robotic Gait Training on Cortical Activity and Gait Function in Hemiparetic Stroke
Effects of robot-assisted gait training on cortical activity and gait function in hemiparetic stroke
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
30
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Seoul, Korea, Republikken, 142884
- National Rehabilitation Center
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
19 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Hemiplegic patients secondary to first cerebrovascular accidents
- Functional ambulation category score 3
- 3 months ≤ Onset ≤ 12 months
- Korean Mini-Mental State Examination score > 24
Exclusion Criteria:
- History of surgery of affected lower limb
- Fracture of affected lower limb
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Robot-assisted gait training
experimental group that applied the end-effector robot-assisted gait training
|
intervention with robot-assisted gait training
|
Aktiv komparator: Treadmill gait training
control group that applied the treadmill gait training
|
intervention with treadmill gait training
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
oxygenated hemoglobin levels
Tidsramme: 4 weeks from baseline
|
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
|
4 weeks from baseline
|
Range of motion of ankle, knee, and hip joint
Tidsramme: 4 weeks from baseline
|
ankle, knee, and hip joint motion of sagittal plane during gait
|
4 weeks from baseline
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
oxygenated hemoglobin levels
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Range of motion of ankle, knee, and hip joint
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
ankle, knee, and hip joint motion of sagittal plane during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Berg Balance Scale
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Berg Balance Scale assess the functional balance ability of participants with observation of 14 tasks, representing functional movements common in daily life.
Each task is scored on a five-point scale (0-4) following the guidelines of the test developers, and the maximum score on this test is 56 which indicates balance ability within the normal range.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Fugl-Meyer Assessment
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Fugl-Meyer Assessment uses to examine the motor function and coordination of affected lower extremity.
It includes 17 items of a 3-point ordinal scale, ranging 0-34, with higher scores indicating lower impairment.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
10m walk test
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
10m walk test is used to examine gait speed, in which participant was asked to walk on a 14 meter of walkway wearing harness with two conditions; with the fastest speed or with self-selected comfortable speed.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Functional ambulation category
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Functional Ambulation Category is used to assess gait ability with 6 levels ranging from 0 to 5 on the basis of the amount of physical support required, regardless of use of an assistive device
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Falls efficacy scale
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Korean version of Falls efficacy scale asks subjects to rank their confidence about their ability not to fall while performing a variety of activities of daily living with a maximum score of 100
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Beck depression inventory
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
21-question multiple-choice self-report inventory, one of the most widely used psychometric tests
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Stroke impact scale
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
health-related quality of life poststroke across 8 domains using a 5-point Likert scale, with the score ranging from 0 to 100 and a higher score indicating better health status
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Dynamic gait index
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
a clinical tool to assess gait, balance and fall risk
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Timed up and go test
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
a simple test used to assess a person's mobility and requires both static and dynamic balance
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
modified Barthel index
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Measure of physical disability used widely to assess behaviour relating to activities of daily living for stroke patients
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
dual task - COWAT
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Controlled Oral Word Association Test, abbreviated COWA or COWAT, is a verbal fluency test that measures spontaneous production of words belonging to the same category or beginning with some designated letter.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
dual task - digit span test
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
The digit span test is a way of measuring the storage capacity of a person's working memory.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Electromyography of lower extremities
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Muscle activity of tibialis anterior, medial gastrocnemius, vastus medialis, biceps femoris, gluteus medius during gait.
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Plantar pressure
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Plantar pressure (great toe, little toe, medial meta, lateral meta, medial arch, lateral arch, heel) during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Spatiotemporal gait parameter data
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
step length, step time, swing time, double limb support time during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
deoxygenated hemoglobin levels
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
total hemoglobin levels
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
cortical activity of primary sensorimotor cortex, premotor cortex, supplementary motor areas, pre-supplementary motor areas, prefrontal cortex during gait
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Balance test using force plate
Tidsramme: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Static standing balance as measured using a force plate: Changes in center-of-pressure velocity and area
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. september 2018
Primær fullføring (Faktiske)
30. november 2019
Studiet fullført (Faktiske)
31. desember 2019
Datoer for studieregistrering
Først innsendt
12. august 2019
Først innsendt som oppfylte QC-kriteriene
12. august 2019
Først lagt ut (Faktiske)
13. august 2019
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
11. februar 2020
Siste oppdatering sendt inn som oppfylte QC-kriteriene
9. februar 2020
Sist bekreftet
1. februar 2020
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- NRC-2017-02-015
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Nei
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
produkt produsert i og eksportert fra USA
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Robot-assisted gait training
-
Chang Gung Memorial HospitalFullførtBrystkreft | BrystrekonstruksjonTaiwan
-
Southern Methodist UniversityFullført